Secondary Complete Cytoreduction in Recurrent Ovarian Cancer: Benefit of Optimal Patient Selection Using Scoring System. Issue 2 (1st February 2014)
- Record Type:
- Journal Article
- Title:
- Secondary Complete Cytoreduction in Recurrent Ovarian Cancer: Benefit of Optimal Patient Selection Using Scoring System. Issue 2 (1st February 2014)
- Main Title:
- Secondary Complete Cytoreduction in Recurrent Ovarian Cancer: Benefit of Optimal Patient Selection Using Scoring System
- Authors:
- Laas, Enora
Luyckx, Mathieu
De Cuypere, Marjolein
Selle, Frederic
Daraï, Emile
Querleu, Denis
Rouzier, Roman
Chéreau, Elisabeth - Abstract:
- Abstract : Objective: Complete tumor cytoreduction seems to be beneficial for patients with recurrent epithelial ovarian cancer (REOC). The challenge is to identify patients eligible for such surgery. Several scores based on simple clinical parameters have attempted to predict resectability and help in patient selection for surgery in REOC. The aims of this study were to assess the performance of these models in an independent population and to evaluate the impact of complete resection. Materials and Methods: A total of 194 patients with REOC between January 2000 and December 2010 were included in 2 French centers. Two scores were used: the AGO DESKTOP OVAR trial score and a score from Tian et al. The performance (sensitivity, specificity, and predictive values) of these scores was evaluated in our population. Survival curves were constructed to evaluate the survival impact of surgery on recurrence. Results: Positive predictive values for complete resection were 80.6% and 74.0% for the DESKTOP trial score and the Tian score, respectively. The false-negative rate was high for both models (65.4% and 71.4%, respectively). We found a significantly higher survival in the patients with complete resection (59.4 vs 17.9 months, P < 0.01) even after adjustment for the confounding variables (hazard ratio [HR], 2.53; 95% confidence interval, 1.01–6.3; P = 0.04). Conclusions: In REOC, surgery seems to have a positive impact on survival, if complete surgery can be achieved. However,Abstract : Objective: Complete tumor cytoreduction seems to be beneficial for patients with recurrent epithelial ovarian cancer (REOC). The challenge is to identify patients eligible for such surgery. Several scores based on simple clinical parameters have attempted to predict resectability and help in patient selection for surgery in REOC. The aims of this study were to assess the performance of these models in an independent population and to evaluate the impact of complete resection. Materials and Methods: A total of 194 patients with REOC between January 2000 and December 2010 were included in 2 French centers. Two scores were used: the AGO DESKTOP OVAR trial score and a score from Tian et al. The performance (sensitivity, specificity, and predictive values) of these scores was evaluated in our population. Survival curves were constructed to evaluate the survival impact of surgery on recurrence. Results: Positive predictive values for complete resection were 80.6% and 74.0% for the DESKTOP trial score and the Tian score, respectively. The false-negative rate was high for both models (65.4% and 71.4%, respectively). We found a significantly higher survival in the patients with complete resection (59.4 vs 17.9 months, P < 0.01) even after adjustment for the confounding variables (hazard ratio [HR], 2.53; 95% confidence interval, 1.01–6.3; P = 0.04). Conclusions: In REOC, surgery seems to have a positive impact on survival, if complete surgery can be achieved. However, factors predicting complete resection are not yet clearly defined. Recurrence-free interval and initial resection seem to be the most relevant factors. Laparoscopic evaluation could help to clarify the indications for surgery. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 24:Issue 2(2014)
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 24:Issue 2(2014)
- Issue Display:
- Volume 24, Issue 2 (2014)
- Year:
- 2014
- Volume:
- 24
- Issue:
- 2
- Issue Sort Value:
- 2014-0024-0002-0000
- Page Start:
- 238
- Page End:
- 246
- Publication Date:
- 2014-02-01
- Subjects:
- Ovarian cancer -- Recurrence -- Surgery -- Scoring system
Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/IGC.0000000000000051 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18053.xml